Open a Free Demat Account !
₹0 AMC, ₹20 Flat Brokerage
Open a Free Demat Account !
₹0 AMC, ₹20 Flat Brokerage
Anondita Medicare Limited
Minimum investment
Bidding date
22 Aug - 26 Aug 2025
Price range
₹137 - ₹145
Minimum quantity
2,000
Minimum investment
₹1,37,000
Issue size
₹69.5 Cr.
IPO doc (link)
RHP docsListing exchange
NSE/BSE
Category | Subscription |
|---|---|
Qualified Institutional Buyers | 46216x |
Retail Individual Investor | - |
Non-Institutional Investor | 495.85x |
Others | - |
Total | - |
Anondita Medicare Ltd., founded in March 2024, is a leading manufacturer of flavored male condoms under its flagship brand “COBRA.” The company has an annual production capacity of 562 million condoms at its modern manufacturing facility in Noida, Uttar Pradesh.
Anondita Medicare caters to both domestic and international markets, exporting products across Southeast Asia, Africa, and the Middle East. The company works in collaboration with global health organizations, NGOs, and government agencies to support family planning and public health initiatives.
With a strong distribution network covering wholesalers, retailers, and e-commerce platforms, Anondita Medicare ensures timely delivery and broad accessibility of its products. As of July 31, 2025, the company employs 280 professionals.
Leading Condom Manufacturer: Anondita Medicare is one of the significant players in India’s condom manufacturing industry, with strong production capabilities and a flagship brand “COBRA.”
Recognized Brand Presence: The company enjoys strong recognition in North India and is gradually building its market share in international territories as well.
Diverse Customer Base: Its customer network includes NGOs, government health programs, wholesalers, retailers, and e-commerce platforms, reducing reliance on a single segment.
Strong Financial Growth: With consistent revenue growth and high margins, the company has demonstrated strong financial performance, supported by increasing profitability and efficient operations.
High Product Concentration: The company is primarily dependent on the condom segment, with limited diversification into other healthcare or medical products.
Competitive Industry Landscape: The sexual wellness and condom manufacturing sector faces intense competition from both domestic and global brands, which may affect market share and pricing power.
Regulatory and Policy Risks: Changes in healthcare regulations, export policies, or government procurement contracts can significantly impact business operations.
N/A
Open Rupeezy account now. It is 100% free and secure.
Active IPOs | |
|---|---|
Company name | Bid starts |
Veegaland Developers | 10-09-2026 |
Manika Plastech | 11-09-2026 |
Hero Motors | 16-09-2026 |
Jindal Supreme India | 16-09-2026 |
Ss Retail | 16-09-2026 |
Sonaselection India | 17-09-2026 |